It may be possible to delay the onset of neurodegenerative diseases with an immunosuppressive drug (rapamycin)

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.13, Iss.9, 2013-09, pp. : 1215-1219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Coenzyme Q10 as a Possible Treatment for Neurodegenerative Diseases

By Flint Beal M.

Free Radical Research, Vol. 36, Iss. 4, 2002-01 ,pp. : 455-460

Informa Healthcare

Access to resources Recommend Favorite

LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases

By Xu Pei Li Dabing Tang Xiaotong Bao Xiaohang Huang Jing Tang Yongping Yang Yang Xu Haiwei Fan Xiaotang

Molecular Neurobiology, Vol. 48, Iss. 3, 2013-12 ,pp. : 715-728

Humana Press, Inc

Access to resources Recommend Favorite

Natural antioxidants for neurodegenerative diseases

By Zhao Baolu

Molecular Neurobiology, Vol. 31, Iss. 1-3, 2005-02 ,pp. : 283-293

Humana Press, Inc

Access to resources Recommend Favorite

Association of micronucleus frequency with neurodegenerative diseases

By Migliore Lucia Copped Fabio Fenech Michael Thomas Philip

Mutagenesis, Vol. 26, Iss. 1, 2011-01 ,pp. : 85-92

Oxford University Press

Access to resources Recommend Favorite

#945;-Synuclein Misfolding and Neurodegenerative Diseases

Current Protein and Peptide Science, Vol. 9, Iss. 5, 2008-10 ,pp. : 507-540

Bentham Science Publishers

Access to resources Recommend Favorite